Clicky

  • Login
  • Register
  • Submit Your Content
  • Contact Us
Thursday, September 19, 2024
World Tribune
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
Submit
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
No Result
View All Result
World Tribune
No Result
View All Result

Leveraging ‘explainable AI’ to resolve Japan’s growing stroke threat

September 18, 2024
in Health
Reading Time: 3 mins read
A A
Leveraging ‘explainable AI’ to resolve Japan’s growing stroke threat
0
SHARES
ShareShareShareShareShare

Leveraging ‘explainable AI’ to resolve Japan’s growing stroke threat

About a million possible cases of atrial fibrillation, a known risk for stroke, go undetected in Japan. A local startup is introducing an innovative AI targeting this growing danger.

Founded in 2019, Cardio Intelligence develops a range of AI-powered solutions for continuous heart monitoring called SmartRobin AI. 

The SmartRobin AI series is based on “explainable AI,” which processes a huge volume of information – an ECG dataset of over 100 million heartbeats – to provide clinicians with simple insights supporting their diagnosis. 

The company claims its AI can produce instant analysis of 24-hour ECG in about three minutes and 7-day ECG in around 15 minutes. 

The AI lineup currently covers both continuous ECG tracking and AFib detection.

Mobihealth News spoke with Yuichi Tamura, CEO of Cardio Intelligence, who discussed more about their latest work in detecting AFib and how they are helping Japan shed light on this silent threat.

Q. ​​You are currently developing a new AI to detect AFib. Where are you now in this process and what can you tell us about this technology and the problem it seeks to solve?

A. We have already obtained medical device approval for the AI system for detecting AFib, and it is currently being sold in Japan. Our technology leverages deep learning algorithms to quickly analyse vast amounts of ECG data collected over seven to 14 days. The primary challenge we are addressing is improving the diagnosis rate of paroxysmal AFib, which often presents no symptoms but can lead to serious complications like stroke if left untreated. By providing clinicians with a reliable early detection tool that minimises the burden on medical staff, we aim to improve patient outcomes and reduce healthcare costs associated with advanced cardiovascular diseases.

Q. Can you share the details of your study findings after testing your AFib AI detection model?

A. When detecting AFib from standard long-term ECGs, our AI model demonstrated a sensitivity of 97% and a specificity of 95%. This research was published prior to our product launch. Recently, we have been conducting clinical studies in collaboration with several leading hospitals in Japan. The positive rate of AFib [detection adoption] has reached 15%, indicating that our AI model is being effectively utilised. We are also working on integrating physician feedback to improve result interpretability and enhancing the user interface to make the system even more user-friendly.

Q. There are many ECG analysis AI solutions currently in the market. How do you set your product suite apart from them? What is your product development strategy and what unique value do your AI products propose?  

A. Our software medical device products are compatible with any existing ECG hardware. Each product features an interface that is easy for physicians and technicians to use. Unlike other black-box solutions, our AI-powered software provides explainable results that allow clinicians to understand the reasoning behind each detection. 

Our development strategy focuses on solving challenges in clinical settings and maximising efficiency in examinations by collaborating with specialists and healthcare providers – we have already secured such clients to ensure our solutions meet real-world needs.

Q. What are your plans for expansion? Have you looked for or received investments over the past few months/years? Which markets do you intend to bring your ECG analysis AI solutions to? 

A. We are actively planning to offer our products outside Japan, particularly in Asia and North America. We have continuously raised funds from strategic investors who share our vision of advancing cardiovascular care through AI technology. We are also exploring partnerships with international healthcare organisations to facilitate our entry into new markets. Our goal is to make our ECG analysis AI solutions available globally, improving cardiac care and patient outcomes worldwide.

_

Yuichi’s responses have been edited for clarity’s sake.

Credit: Source link

READ ALSO

Amino Health, Motive Practicing Wisley unveil way to bolster ACO performance

Amino Health, Motive Practicing Wisely unveil way to bolster ACO performance

ShareTweetSendSharePin
Previous Post

Experts explain how hundreds of Hezbollah pagers exploded simultaneously

Next Post

Jets’ C.J. Mosley, D.J. Reed ’50-50′ to play against Patriots

Related Posts

Amino Health, Motive Practicing Wisley unveil way to bolster ACO performance
Health

Amino Health, Motive Practicing Wisley unveil way to bolster ACO performance

September 18, 2024
Amino Health, Motive Practicing Wisely unveil way to bolster ACO performance
Health

Amino Health, Motive Practicing Wisely unveil way to bolster ACO performance

September 18, 2024
General Catalyst launches institute to boost global resilience through innovation
Health

General Catalyst launches institute to boost global resilience through innovation

September 18, 2024
Personalising IBD management with EMR data
Health

Personalising IBD management with EMR data

September 18, 2024
‘Small language’ AI detects depression in Korea
Health

‘Small language’ AI detects depression in Korea

September 18, 2024
Q&A: Headspace on reproductive rights in an election cycle
Health

Q&A: Headspace on reproductive rights in an election cycle

September 17, 2024
Next Post
Jets’ C.J. Mosley, D.J. Reed ’50-50′ to play against Patriots

Jets' C.J. Mosley, D.J. Reed '50-50' to play against Patriots

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

What's New Here!

It’s a good year to buy the vanilla iPhone 16 (and avoid the SE at all costs)

It’s a good year to buy the vanilla iPhone 16 (and avoid the SE at all costs)

September 10, 2024
Nestle CEO replacement not such a bad thing for investors: Analyst

Nestle CEO replacement not such a bad thing for investors: Analyst

August 23, 2024
Arch Manning showed he’s ready in tantalizing Texas glimpse

Arch Manning showed he’s ready in tantalizing Texas glimpse

September 15, 2024
General Catalyst launches institute to boost global resilience through innovation

General Catalyst launches institute to boost global resilience through innovation

September 18, 2024
Natural Delights® Celebrates Internal Promotions as Company Continues to Expand

Natural Delights® Celebrates Internal Promotions as Company Continues to Expand

August 21, 2024
Mindset Care raises  million to streamline disability benefit applications

Mindset Care raises $13 million to streamline disability benefit applications

August 22, 2024
Booking Holdings CEO Glenn Fogel on how AI will change trip planning

Booking Holdings CEO Glenn Fogel on how AI will change trip planning

September 13, 2024

About

World Tribune is an online news portal that shares the latest news on world, business, health, tech, sports, and related topics.

Follow us

Recent Posts

  • Rory McIlroy fans think he has no idea who Tom Holland is in viral video
  • Tom Steyer of Galvanize Climate Solutions is funding technology to save the planet
  • Amazon introduces Amelia, an AI assistant for third-party sellers
  • Our verdict on the iPhone 16 Pro

Newslatter

Loading
  • Submit Your Content
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2024 World Tribune - All Rights Reserved!

No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food

© 2024 World Tribune - All Rights Reserved!

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In